carbohydrate was found by Wilson and Wiley in the serum of a patient with streptococcal parotitis, otitis, and septicemia (9). Halbert described immunodiffusion reactions with human gamin a globulin and Streptomyces albus enzymeprepared A polysaccharide and an A polysaccharide-protein complex (8) . In these studies, A carbohydrate antibody was not quantified nor were surveys of sera from different sources reported.
Materials and Methods
Polysaceharide Antigens.--Ethanol and acetone-precipitated fractions of A polysaceharide were prepared from diisopropyl fluorophosphate (DFP)-treated Streptomyces albus enzyme lysates of streptococcal cell walls as described in the preceding paper (6) . Similar polysaccharide fractions were precipitated from lysates obtained with S. albus enzyme that was not treated with DFP. Ethanol and acetone fractions of A-variant polysaccharide (19) were isolated from lysates of cell walls of the T27A strain of streptococci according to the methods employed for A polysaceharide. Group A carbohydrate was also obtained from cell walls by extraction with formamide and purified with ion exchange resins (20) . Specific enzymatic hydrolysis of preparations of A polysaceharide with A enzyme, which selectively destroys A serologic activity, was performed at pH 6, r/2 0.2, at 25 ° and 37 ° C for 20 to 24 hours as described by MeCarty (21) . Dr. 1VL McCarty generously provided the A enzyme.
Column Ckromatograpky.--Chromatography of polysaccharide preparations on CM cellulose was performed according to Peterson and Sober (22) . Columns 0.9 x 25 cm were used. Gradient elution was performed with phosphate buffer, pH 6.4, 1"/2 0.01; the ionic strength was gradually increased to 0.5 with NaC1.
Preparation of Serum Specimens.--Hyperimmune rabbit sera containing antibody to A and
A-variant polysaccharides were prepared according to methods described by McCarty and Lancefield (19) . Human serum specimens were collected in the usual manner and stored at -20°C, or at refrigerator temperature. All sera used in hemagglutination tests were centrifuged and passed through a Millipore filter (porosity 0.45/z) for clarification and inactivated by heating to 60°C for 15 minutes. They were then absorbed with human O erythrocytes by mixing 1 volume of serum with 1 volume of packed erythrocytes (RBC). The suspension was kept at room temperature for 10 minutes with occasional mixing and then centrifuged at 2500 P.r~ for 20 minutes at 2°C. The serum was carefully removed from the cells and stored at --20 ° or at 4°C. All serum dilutions were made with buffered saline, pH 7.2 (23) containing 1 per cent inactivated normal rabbit serum (NRS) that had been absorbed with human O RBC.
Preparation of Reagents for Hemagglutinati~n and Hemagglutination
Inhibition.-Human 0 erythro~ytes: Several type O donors were used. Cells from one donor produced more compact, clear-cut agglutination of RBC; therefore, cells from this donor were almost always used for comparing various sera or antigens. RBC were collected in ACD (24) solution and centrifuged at 2000 ~ at 2°C (all centrifugations were performed at this temperature) for 30 minutes. The supernatant fluid and the huffy coat were removed and the RBC resuspended in ACD solution and centrifuged 20 minutes. This was repeated twice and the last centrifugation was run for 30 minutes to measure the packed RBC volume. RBC were stored as a 50 per cent suspension in ACD solution of 2°C for no longer than 4 days.
To prepare a 2.5 per cent suspension of RBC for treatment with tannic acid, 1 ml of 50 per cent RBC was added to 20 ml of pH 7.2 buffer, mixed and centrifuged at 1500 RPM for 10 minutes. The supernatant fluid was removed and the RBC resuspended in 19.5 ml of pH 7.2 buffer.
Preparation of Tanned RBC.--A 1 : 100 stock solution of reagent grade tannic acid was made in 0.85 per cent saline weekly and kept at 2°C. Each day, a 1:20,000 solution of tannic acid in pH 7.2 buffer was prepared. Then 2 volumes of 2.5 per cent suspension of RBC were mixed with 1 volume of 1:20,000 tannic acid and 1 volume of pH 7.2 buffer and incubated at 37°C for 10 minutes. The suspension was centrifuged at 1500 ~M for 10 minutes and the supemate removed. The RBC were dispersed in the same volume of pH 7.2 buffer and centrifugation repeated. The RBC were then added to sufficient 0.85 per cent saline to make a 2.5 per cent suspension.
Sensitization of Tanne~ RBC.--One volume of 2.5 per cent tanned RBC was mixed with 0.9 to 0.4 volume of pH 6.4 buffered saline (23) and 0.1 to 0.6 volume of antigen in distilled water or pH 6.4 buffered saline. The suspension was incubated at 37"C for 30 minutes with occasional mixing; it was then centrifuged at 1500 m,M for 10 minutes and the supernate removed. To wash the sensitized RBC, they were resnspended in pH 7.2 buffer containing 2 per cent heatinactivated bovine serum albumin (BSA) to a final concentration of RBC of 1.25 per cent and centrifuged at 1500 xp~t for 10 minutes. This was repeated once; then the RBC were added to pH 7.2 buffer containing 2 per cent BSA to make a 2.5 per cent suspension of sensitized RBC. An unsensitized 2.5 per cent RBC suspension was prepared in the same manner without added antigen. Sensitized RBC were prepared fresh daily. Because agglutination of RBC was less compact in the presence of merthiolate, it was not put in any of the reagents except the original undiluted serum specimen to be tested. Bacterial contamination also interfered with hemagglutination so that all reagents were autoclaved or sterilized by filtration, and sterile technique was used in all procedures from the drawing of blood through the preparation of sensitized cells.
Hamagglutination.--Dilutions of sera to be tested were pipetted in 0.5 ml amounts into carefully cleaned 10 x 75 mm test tubes and 0.05 ml of sensitized RBC suspension was added. The tubes were shaken to mix sensitized cells and serum thoroughly and then kept at 4°C overnight. The reactions were graded from 0 to 4+ according to criteria slightly modified from those described by Stavitsky (23) . Serum controls consisted of one or more of the lower serum dilutions reacted with non-sensitized, tanned RBC. For antigen controls, sensitized, tanned RBC were reacted with dilutions of normal rabbit or normal human sera, rabbit sera containing heterologous antibody, and with saline. A standard serum producing positive hemagglutination of a known titer was included with each group of sera tested.
Hemagglutination Inhibition.--Solutions of antigens for inhibition were diluted in pI-I 7.2 buffer containing 1 per cent NRS. The dilutions of inhibiting antigens (usually a 100-to 1000-fold range) were added in 0.1 ml amounts to 0.4 ml of one or more selected dilutions of a serum of known hemagglutination titer. The tubes were mixed and allowed to stand at room temperature for 30 minutes. Then 0.05 ml of sensitized RBC was added and the tubes were shaken again and refrigerated overnight. Reactions were graded as in hemagglutination. A titration of the hemagglutinating system without inhibitor was made concurrently.
KESO'LI~
After it was found in preliminary experiments that certain preparations of A carbohydrate would attach to tanned human O erythrocytes and produce agglutination in the presence of specific antibody, other experiments were conducted to determine optimum conditions for the reaction. The conditions described under Materials and Methods for concentration of RBC, tannic acid, pH, temperature, and time for tavnlng and sensitizing RBC represent optima. Treatment of RBC with tannic acid was essential. Hemagglutination in the A polysaccharide system was much better at 4 ° than at 25 ° or 37°C. Reactions could be read as early as 4 hours but were maximal after 16 hours. Time and temperature had tittle if any effect on the reaction of antibody with inhibiting antigen.
Preparations of Polysacckaride Effective as Hemagglutinating Antigens.--A
survey of a number of preparations of A polysaccharide revealed marked differences in their ability to sensitize tanned RBC for hemagglutination.
To compare the various forms of polysaccharide, a volume of tanned 0 RBC was mixed with an equal volume of polysaccharide of the concentration listed in Table I for sensitization. After washing, the sensitized cells were added to serial dilutions of a Group A antistreptococcal serum and to two dilutions of a Group B serum. Table I . Sensitization of tanned RBC with formamide-extracted A carbohydrate could not be accomplished. Of several preparations tested, only one lot (No. 10) of polysaccharide prepared with S. a/bus enzyme without DFP sensitized RBC for hemagglutination at relatively high antigen concentrations. A-carbohydrate purified from DFP-treated S. albns enzyme lysates produced uniformly good sensitization of RBC at concentrations less than 5/zg of polysaccharide rhamnose per ml. Mter fractionation of the 0.6 saturated (NI-I,)2SO4 supernate of DFP-S. albus enzyme lysates with ethanol and acetone (6), hemagglutinating antigen was found only in the ethanol precipitate.
TABLE I

Itemagglutination Reactions of Preparations of A Polysaccharide
Treatment of ethanol-precipitated A polysaccharide with crystalline trypsin (10 #g trypsin per ml at pH 8, 37°C for 5 hours; reaction stopped with DFP) abolished the ability to sensitize tanned RBC for hemagglutination. Since the mucopeptide is the only portion of enzymatically prepared A carbohydrate that can be hydrolyzed by trypsin, it may be inferred from the trypsin effect that the attachment of A polysaccharide to tanned O erythrocytes is effected by way of the mucopeptide.
Further fractionation of ethanol-precipitated polysaccharide by chromatography on CM cellulose has also provided evidence of the dependence of sensitization of RBC on the mucopeptide conjugated to A polysaccharide. The major portion of ethanol-precipitated A carbohydrate was not adsorbed to CM cellulose equilibrated with pH 6.4, F/2 0.01 phosphate buffer and emerged from the column with the initial solvent. This fraction contained relatively less sensitizing antigen than a small portion of the A polysacchafide eluted from the column between ionic strength 0.05 and 0.1. The latter fraction contained from 2.5 to 3 times as much mucopeptide as the major unadsorbed polysaccharide fraction.
Specificity of A Polysavckaride Hemagglutination.--Reactions demonstrating
the specificity of A polysaccharide hemagglutination are presented in Table H . Agglutination of tanned RBC sensitized with A polysaccharide was demonstrable with Group A antistreptococcal rabbit sera but not with Groups B, C, or G antisera.
Sensitization of human O RBC with the ethanol-precipitated fraction of A carbohydrate was performed as detailed in the Materials and Methods section. Similar conditions were employed in treating tanned O RBC with several preparations and concentrations of A-variant polysaccharide. To sensitize RBC with A ermyme-trcated A carbohydrate, several milligrams of ethanol polysaccharide were hydrolyzed with A enzyme. The hydrolysate was then diluted, and a number of concentrations were reacted with tanned O RBC in the usual manner.
Tanned RBC sensitized with A polysaccharide that had been treated with A enzyme which hydrolyzes the immunologically specific A determinant (21) were not agglutinated by Group A or other antistreptococcal rabbit sera. Attempts to sensitize tanned RBC with A-variant polysaccharide produced variable results. Clear-cut hemagglutination patterns were not obtained, and when agglutination did occur it was of low titer. Reactions with A as well as A-variant sera were usual; often the titer with A antiserum was greater than that of the A-variant serum. It is likely that the positive reactions were due to Table III . A-variant polysaccharide had no inhibiting effect. The evidence that trypsin-treated A polysaccharide was a good inhibitor provided further indication that the action of trypsin on the RBC-sensifizing property of the ethanol fraction of A polysaccharide previously described (Table I) was not on the immunologic determinant but on the site of attachment of the polysaccharide molecules to the tanned red cell. Exposure of A carbohydrate to A enzyme, which removes the /%N-acetylglucosamine serologic determinant (21), destroyed its hemagglutination-inhibiting ability. McCarty, in establishing the identity of the A polysaccharide determinant as /3-linked N-acetylglucosamine, demonstrated significant inhibition of the precipitin reaction of A polysaccharide and A antibody by Nacetylglucosamine and phenyl-/3-N-acetylglucosaminide (25) . Experiments employing these reagents in concentrations of 0.02 to 2000 #g per ml as inhibitors of A polysaccharide hemagglutination were unsuccessful. An example of the inability of several concentrations of /3-phenyl-N-acetylglucosaminide to inhibit A polysaccharide hemagglutination is illustrated in Table III . sepsis, known to contain precipitating antibody to A carbohydrate, were compared with Group A rabbit antisera. Serum from one of these patients, Sch., was kindly provided by Dr. A. T. Wilson who previously described capillary precipitation and immunoelectrophoretic reactions of this serum with purified A carbohydrate (9) . The second patient, Dra., was one of several with group A streptococcal sepsis, observed and treated at Cleveland Metropolitan General Hospital, who were found to have A carbohydrate precipitating antibody in their sera. Hemagglutination and hemagglutination inhibition reactions of sera from Sch. and Dra. with preparations of A polysaccharide and enzyme-treated A polysaccharide were qualitatively identical with the reactions of these materials with antistreptococcal rabbit sera described above and illustrated in Tables I to III . Experiments illustrating reactions of the ethanolprecipitated fraction of A carbohydrate, before and after treatment with A enzyme, as sensitizing and inhibiting antigen with Dra. serum are presented in Table IV After demonstration of the specificity of A polysaccharide hemagglutination with human sera, serum specimens from patients with various forms of streptococcal infection, non-suppurative streptococcal sequelae, and from normal children and adults were tested to obtain information about the nature of the A carbohydrate antibody response in man. Most of the sera examined contained A carbohydrate antibody, and considerable variation in the titers of this antibody was evident. Quantitative comparisons of sera from various categories of streptococcal disease were made after experiments were performed to determine the accuracy of the titration of A polysaccharide antibody by hemagglutination. Repeated titrations of several human and rabbit sera were made; titrations of the same serum did not usually result in a variation of more than one dilution increment in the end point (reaction of 1+ or more). The hemagglutination titers of A antibody in a series of rabbit sera were roughly proportional to mounts of A antibody in these sera determined by quantitative precipitation. Therefore, estimation of A polysaccharide antibody by hemagglutination is [[ Acute phase streptococcal infection. ¶ Acute rheumatic fever. ** "Normal" child. ~ "Normal" adult.
probably comparable to fitrations of other streptococcal antibodies which are similarly subject to the limitations of the serum dilution technique. A typical titration of A carbohydrate antibody in sera from normal children, adults, and patients during several phases of streptococcal infection and rheumatic fever is presented in Table V . Serum Dra. I was obtained during the acute phase of streptococcal sepsis; serum Dra. 2 drawn 3 weeks later had the same titer of A antibody: 800. A rise in antibody to 3200 was detected in a third serum obtained 8 weeks after the second. Serum Sch. was from the patient with sepsis studied by Wilson. Sera from Car., Dav., Fra., and Sev. (2) were collected during the convalescent stage of untreated streptococcal pharyngitis, 5 to 7 weeks after the onset of symptoms. In the second serum from Sev., which was obtained 5 weeks after the first specimen, a rise in the A antibody titer from 100 to 400 was found. A-polysaccharide hemagglufinating antibody titers of 200 to 800 units were found in the three serum specimens from patients with acute rheumatic fever. Sixty to 70 per cent of normal children and adults were found to have demonstrable A carbohydrate antibody in their sera; the titers were usually less than 100. Children were less likely to have detectable A antibody, depending upon age and epidemiological circumstances. In a small collection of sera from young children with viral disease, 75 per cent did not contain A-hemagglutinating antibody, whereas 8 of 9 children in an orphanage population where many streptococcal carriers were present had measurable antibody titers. In several sera from infants collected during the acute phase of streptococcal infection, A carbohydrate antibody was not present nor did it appear in specimens collected 2 to 3 weeks later. In adults who had A antibody initially, a rise in antibody did not occur until 4 weeks or more after streptococcal infection. A antibody fiters decreased minimally or persisted for at least several months.
If the A polysaccharide antibody titers of normal persons and patients with localized streptococcal infections, sepsis, rheumatic fever, and glomerulonephritis are collectively examined, a variation in the intensity of antibody response similar to that of several other streptococcal antibodies (1, 2) is found. A summary of the antibody determinations of 86 sera showing the range and the median titers in these categories, is presented in Table VI . Normal persons were found to have a median fiter of A hemagglufinating antibody of 50. Patients convalescent from Group A streptococcal infections demonstrated a fourfold greater median value. The median response in patients with rheumatic fever and glomerulonephritis is somewhat higher than that following uncomplicated infection. Although few patients with sepsis were studied, the greatest antibody response was evident in this group experiencing intensive antigenic stimulus.
DISCUSSION
Previous experience with the measurement of streptococcal antibodies in man has demonstrated that highly sensitive techniques are necessary to detect the small amounts of a specific antibody formed after natural infection (26) . In this investigation, hemagglutinafion was selected as a method for measuring A polysaccharide antibody because of its sensitivity (23) and because the specificity of the hemagghitination reaction could be critically tested with the specific /%acetylglucosaminidase and the /~-acetylglucosaminide inhibitor employed by McCarty in the lucid demonstration of the chemical nature of the A carbohydrate determinant (21, 25) .
Recent evidence that mucopepfide components of the cell wall remain conjugated to enzymicaUy released A polysaccharide (6, 27) provided another reason for attempting hemagglutination with the A carbohydrate; certain mucopeptide fragments might contain reactive groups more likely to bind polysaccharide to tannic acid-treated erythrocytes. Substantiation for this hypothesis was found in the observation that only a particular, mucopeptidecontaining fraction of A polysaccharide solubilized by DFP-treated S. a/bus enzyme, namely the ethanol precipitate and chromatographic fractions of this precipitate, attached to RBC; whereas the acetone precipitate of DFP-treated S. a/bus lysates, S. a/bus lysates (with one exception), and formamide-extracted A carbohydrate would not sensitize RBC. It was also found that trypsin destroyed the capacity of the ethanol A carbohydrate fraction to attach to tanned RBC without altering its activity in hemagglutination inhibition.
A series of experiments was presented to identify the hemagglutinating reactant in human sera as A carbohydrate antibody. First, it was demonstrated that A polysaccharide-sensitized RBC reacted with Group A rabbit antisera but not with antisera of Groups B, C, and G. This reaction was inhibited by A carbohydrate and abolished by treatment of the RBC-sensitizing antigen with A enzyme which removes the immunologically specific A carbohydrate determinant. Then, it was shown that A polysaccharide inhibited hemagglutination of the same antigen-coated RBC by human sera known to contain A carbohydrate antibody. This reaction was eliminated by treatment of the inhibiting antigen with A enzyme and by A enzyme hydrolysis of the sensitizing antigen before it was reacted with tanned RBC.
No ready explanation is forthcoming to account for the failure to demonstrate inhibition of A polysaccharide hemagglutination by N-acetylglucosamine or phenyl-N-acetylglucosaminide which McCarty found effective in producing partial inhibition in the A carbohydrate-A antibody precipitating system (25) . It has been suggested that incomplete inhibition in this precipitating system and lack of cross-reactivity between A polysaccharide and azophenyl-Nacetylglucosaminide antisera (25) occur because A antibody-combining sites are mainly complementary to A carbohydrate oligosaccharides with terminal fl-N-acetylglucosamirfide units (28) . It is possible that the determinants of the A carbohydrate fixed to tanned RBC are by chance those that react only with A antibody with combining sites complementary to oligosaccharides which monomeric inhibitors will not satisfy. It is also possible that inhibition of hemagglutination was not demonstrated because the glucosaminide inhibitor was employed in too low a concentration.
The studies of A polysaccharide antibody in human sera that have been conducted do not as yet permit accurate description of the natural history of the A carbohydrate antibody response following streptococcal infection, but several tentative features emerge. Most persons except infants and some young children have circulating A carbohydrate antibody. The A antibody response appears to be relatively slow following streptococcal infection and is more persistent, resembling M antibody in contrast to streptolysin O antibody (2, 26, 29) . Patients with the non-suppurative sequelae seem to have a somewhat greater A antibody response than those experiencing uncomplicated streptococcal infection.
SUMMARY
A hemagglutination method employing tanned human O erythrocytes sensitized with purified Group A streptococcal polysaccharide has been developed to measure A polysaccharide antibody in antistreptococcal rabbit and human sera.
The reaction of sensitized RBC with known Group A streptococcal rabbit antisera, inhibition of hemagglutination with A polysaccharide, and abolition of hemagglutinafion and hemagglutination-inhibition by exposure of polysaccharide antigen to A enzyme, which destroys the specific immunologic determinant of A carbohydrate, were utilized to demonstrate the specificity of this hemagglutinating system.
The results of A polysaccharide antibody determinations on sera from normal persons, patients convalescent from streptococcal infection, and patients with non-suppurative streptococcal sequelae are presented. 
